SEVERE HEMOPHILIA A
Clinical trials for SEVERE HEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new SEVERE HEMOPHILIA A trials appear
Sign up with your email to follow new studies for SEVERE HEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Three-Year study tests if new hemophilia drug protects joints and boosts activity
Disease control OngoingThis study is observing people with moderate to severe hemophilia A who are switching to a preventive drug called emicizumab. Researchers want to see how well this long-term treatment protects their joints from damage and helps them stay physically active over three years. The st…
Matched conditions: SEVERE HEMOPHILIA A
Phase: PHASE4 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 04, 2026 00:35 UTC
-
New hope for babies with severe bleeding disorder
Disease control OngoingThis study is testing a preventive injection called emicizumab in babies from birth to 12 months old who have severe hemophilia A, a condition where blood doesn't clot properly. The main goal is to see if regular injections every two weeks can safely reduce the number of bleeding…
Matched conditions: SEVERE HEMOPHILIA A
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New program aims to ease the burden for families facing rare childhood diseases
Symptom relief ENROLLING_BY_INVITATIONThis study is testing a support program called FACE-Rare for families caring for children with serious rare diseases. The program aims to help families plan for future medical decisions and address their own support needs. Researchers want to see if this improves the family's qua…
Matched conditions: SEVERE HEMOPHILIA A
Phase: NA • Sponsor: Children's National Research Institute • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC